Cargando…
Inhaled therapy in cystic fibrosis: agents, devices and regimens
KEY POINTS: There have been significant advances in both inhalation medicines and delivery devices with “intelligent nebulisers” and “dry-powder inhalers” becoming commonplace in CF care. Inhaled medicines generate high levels of a drug within the airways with limited systemic effects, offering safe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487378/ https://www.ncbi.nlm.nih.gov/pubmed/26306111 http://dx.doi.org/10.1183/20734735.021014 |